TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Active Biotech AB ( (SE:ACTI) ) has provided an announcement.
Active Biotech AB has announced its upcoming Annual General Meeting (AGM) scheduled for May 28, 2025. Key agenda items include the re-election of board members and auditors, with no dividend to be paid as the company’s accumulated loss will be carried forward. The meeting will also address board remuneration and share issue authorization, impacting the company’s governance and financial strategy moving forward.
More about Active Biotech AB
Active Biotech AB is a biotechnology company based in Lund, Sweden, focusing on the development of pharmaceuticals for the treatment of autoimmune diseases and cancer. The company is engaged in research and development to bring innovative therapies to market, aiming to improve patient outcomes in these areas.
YTD Price Performance: -21.43%
Average Trading Volume: 26,358
Technical Sentiment Signal: Strong Buy
Current Market Cap: €9.72M
See more data about ACTI stock on TipRanks’ Stock Analysis page.